Corrigendum to Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG): Annals of Oncology, Volume 26, Issue 7, July 2015, Pages 1333-1340

Affiliations

• ¹ Department of Medical Oncology, University General Hospital of Heraklion, Heraklion, Greece. Electronic address: medoncsec@med.uoc.g.
• ² Oncology Unit, General Hospital of Heraklion 'Venizelio', Greece.
• ³ Department of Medical Oncology, Elena Venizelou Hospital, Athens, Greece.
• ⁴ Department of Medical Oncology, University General Hospital of Alexandroupolis, Alexandroupolis, Greece.
• ⁵ Department of Medical Oncology, Bioklinic of Thessaloniki, Thessaloniki, Greece.
• ⁶ Department of Medical Oncology, Theageneio Hospital, Thessaloniki, Greece.
• ⁷ Department of Medical Oncology, 251 Airforce General Hospital, Athens, Greece.
• ⁸ Department of Medical Oncology, Metaxa Hospital, Athens, Greece.
• ⁹ Department of Medical Oncology, University of Crete, School of Medicine, Heraklion, Greece.